Complex treatment of non-alcoholic fatty liver disease: experience of the use of hepatoprotectors

Journal Title: Сучасна гастроентерологія - Year 2018, Vol 0, Issue 2

Abstract

Objective — to evaluate the complex therapy effects at the levels of cytokeratin (CK)­-18, fibroblast growth factor (FGF)-­21 and metabolic parameters of non­alcoholic fatty liver disease (NAFLD) patients. Materials and methods. examinations involved 90 patients with NAFLD, aged 30 to 60 years (the men age (48.61 ± 4.1) years). The control group consisted of 20 practically healthy volunteers. Gender difference between groups wasn’t significant. Levels of SC­-18 and FGF-­21 with the use immune enzyme method with ELISA kits were performed at baseline and 1 months after the beginning of treatment with combination of ursodeoxycholic acid and ademetionine, Results. Before the treatment, NAFLD patients demonstrated the increased liver enzymatic activity (р ≤ 0.05); lipid profile indices (p ≤ 0.05); the increased levels of insulin and HOMA­IR (p = 0.002), and plasma levels of cytokines CK-­18 and FGF-­21 (p ≤ 0.05). After 1 months of treatment, the following positive effects were revealed: reduction of ALT and AST levels (p ≤ 0.05), decrease of glucose levels by 10.5 %, HOMA index by 41 % (p = 0.001), level of total cholesterol decreased from 5.6 to 4.89 mmol/L, triglycerides’ levels from 1.7 to 1.24 mmol/L (p = 0.001). Conclusions. The combined therapy of ademetionine and ursodeoxycholic acid in patients with NAFLD promoted the reduction of the transaminases’, glucose levels and HOMA­index, resulted in the eliminating of hyperlipidemia and hypertriglyceridemia, as well as reducing of apoptotic processes in the liver.

Authors and Affiliations

O. Ya. Babak, K. A. Lapshyna, А. M. Chernyak

Keywords

Related Articles

The use of proton pump inhibitors in the general clinical practice: advantages and disadvantages

The article presents modern views on the use of proton pump inhibitors in clinical practice with account of the patients’ age, therapyduration and comorbidity. The analysis has been performed for the literature data and...

The relationship between the body mass index and the Firmicutes/Bacteroidetes ratio in the intestinal microbioume of the adult population of Ukraine

Objective — to investigate the difference in the composition of the main intestinal microbiota types in the adult population of Ukraine and their relationship with the body mass index (BMI). Materials and methods. Invest...

The use of probiotics for the prevention and correction of the antibiotic resistance

The antibiotic resistance interferes with the effective prevention and treatment of a number of infections, caused by bacteria, fungi etc., and its quantity is constantly increased. Without effective antibiotics, the eff...

The role of vegetative and emotional disorders in the chronization of duodenal peptic ulcer

Objective — to define the role of vegetative and emotional disorders in the chronization of duodenal peptic ulcer (DPU). Materials and methods. The study involved 62 patients (39 men і 23 women) with DPU, aged 18 to 42...

Complex therapy of non-alcoholic fatty liver disease in combination with the syndrome of intestinal bacterial overgrowth

Objective — to study the effects of three-month administration of the combined cytoprotector L-Betargin on the lipid and carbohydrate metabolism, biochemical markers of liver damage, the degree of its steatosis and fibro...

Download PDF file
  • EP ID EP295148
  • DOI -
  • Views 115
  • Downloads 0

How To Cite

O. Ya. Babak, K. A. Lapshyna, А. M. Chernyak (2018). Complex treatment of non-alcoholic fatty liver disease: experience of the use of hepatoprotectors. Сучасна гастроентерологія, 0(2), 32-36. https://europub.co.uk/articles/-A-295148